GlassScriptPhysician profile
P V Ravindra
NPI 1235116377
$5,076.18
in general payments reported to CMS, 2019-2025
31 companies · $1,298 in 2025
The $1,298 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $399 · 2020: $149 · 2021: $467 · 2022: $753 · 2023: $1,014 · 2024: $997 · 2025: $1,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,308.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,308.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $834.22 | 2020-2025 | Mitraclip, Triclip |
| Medtronic, INC. | $546.78 | 2022-2025 | Cobalt Dr Mri Surescan, Ffrangio, Corevalve Evolut R |
| Boston Scientific Corporation | $441.77 | 2023-2024 | Watchman, Watchman Access System, Watchman Flx |
| Janssen Pharmaceuticals, INC | $348.57 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $338.48 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $272.18 | 2019-2025 | Jardiance |
| Impulse Dynamics (USA) INC. | $238.67 | 2022-2024 | Optimizer, Optimizer |
| Amgen INC. | $230.93 | 2019-2023 | Repatha |
| Pfizer INC. | $187.66 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $180.79 | 2022-2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $165.02 | 2019-2025 | Lokelma, Farxiga |
| Atricure, INC. | $155.48 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $148.16 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $139.22 | 2022-2025 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $137.30 | 2019-2025 | Lifevest |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $126.86 | 2025 | Sapien 3 Ultra Resilia |
| Novo Nordisk INC | $103.34 | 2023-2025 | Ozempic, Rybelsus |
| Medtronic Vascular, INC. | $98.59 | 2019 | |
| Cardiva Medical, INC. | $89.77 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Philips North America LLC | $49.42 | 2022-2024 | (Ck4) Mcot |
| Abiomed | $33.39 | 2024-2025 | Impella |
| Scpharmaceuticals INC. | $29.55 | 2023 | |
| Siemens Medical Solutions USA, INC. | $27.11 | 2024 | Syngo Dynamics |
| Heartflow, INC. | $25.06 | 2025 | |
| Angiodynamics, INC. | $23.76 | 2023 | Alphavac |
| Kiniksa Pharmaceuticals, LTD. | $21.79 | 2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $20.66 | 2024 | |
| Irhythm Technologies, INC. | $19.90 | 2023 | Zio Xt Patch |
| Medicomp INC | $15.90 | 2022 | |
| Gilead Sciences, INC. | $13.62 | 2019 | |
| Terumo Medical Corporation | $12.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw P Ravindra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.